Women who sued the African-American hair care industry leader may be entitled to financial compensation if the cosmetics company is found liable for acting negligently or intentionally. If you or a loved one developed uterine cancer or ovarian cancer, after using SoftSheen-Carson chemical hair relaxer products, you might be entitled to financial compensation.
The National Institutes of Health (NIH) completed a major clinical study that found evidence that chemical hair relaxer products contain endocrine-disrupting and carcinogenic chemicals that could cause uterine cancer. The study found a higher risk of uterine cancer among women who were using chemical hair relaxers compared to women who used no chemical hair relaxer products. The Chicago-based SoftSheen-Carson L'Oreal makes and sells hair relaxers that contain EDCs:
The National Institutes of Health's study led to product liability lawsuits against SoftSheen-Carson and other chemical hair relaxer manufacturers. The company faces a proposed class action over its alleged failure to disclose that some of its chemical hair straightening products contain endocrine-disrupting chemicals known to be harmful to health. Plaintiffs in these lawsuits claim that these toxic chemicals led to the development of hormone-sensitive diseases such as:
- uterine cancer (endometrial cancer, uterine sarcoma)
- ovarian cancer (non-serous and serous tumors)
To file a toxic hair relaxer claim against SoftSheen-Carson, you should meet the following eligibility requirements:
- you must have used SoftSheen-Carson chemical hair relaxer products for at least 2 - 5 years
- you must have used SoftSheen-Carson chemical hair relaxer products at least four times a year
- you must have been diagnosed with uterine or ovarian cancer.
Key facts
Active MDL
MDL 3060, N.D. Ill.
Key NIH study
Sister Study, 2022
Increased uterine cancer risk
2.5×